Shandong Xinhua Pharmaceutical Company Limited (0719.HK)
HKD 5.78
(0.0%)
HKD 5.78
(0.0%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 8.1 Billion CNY | 7.97% |
| 2022 | 7.5 Billion CNY | 14.37% |
| 2021 | 6.56 Billion CNY | 9.23% |
| 2020 | 6 Billion CNY | 7.13% |
| 2019 | 5.6 Billion CNY | 7.65% |
| 2018 | 5.2 Billion CNY | 15.33% |
| 2017 | 4.51 Billion CNY | 12.47% |
| 2016 | 4.01 Billion CNY | 11.62% |
| 2015 | 3.59 Billion CNY | 0.2% |
| 2014 | 3.58 Billion CNY | 13.25% |
| 2013 | 3.16 Billion CNY | 6.67% |
| 2012 | 2.97 Billion CNY | 1.16% |
| 2011 | 2.93 Billion CNY | 12.37% |
| 2010 | 2.61 Billion CNY | 12.59% |
| 2009 | 2.32 Billion CNY | 10.73% |
| 2008 | 2.09 Billion CNY | 11.13% |
| 2007 | 1.88 Billion CNY | 13.18% |
| 2006 | 1.66 Billion CNY | -1.72% |
| 2005 | 1.69 Billion CNY | 12.26% |
| 2004 | 1.51 Billion CNY | 13.76% |
| 2003 | 1.32 Billion CNY | 13.2% |
| 2002 | 1.17 Billion CNY | 6.76% |
| 2001 | 1.09 Billion CNY | 5.29% |
| 2000 | 1.04 Billion CNY | 9.83% |
| 1999 | 950.66 Million CNY | -2.38% |
| 1998 | 973.88 Million CNY | 6.36% |
| 1997 | 915.63 Million CNY | 8.72% |
| 1996 | 842.2 Million CNY | 18.3% |
| 1995 | 711.89 Million CNY | 33.4% |
| 1994 | 533.67 Million CNY | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q3 | 2 Billion CNY | -11.34% |
| 2024 Q1 | 2.47 Billion CNY | 54.35% |
| 2024 Q2 | 2.25 Billion CNY | -8.77% |
| 2023 Q4 | 1.6 Billion CNY | -12.16% |
| 2023 Q2 | 2.03 Billion CNY | -23.0% |
| 2023 FY | 8.1 Billion CNY | 7.97% |
| 2023 Q3 | 1.82 Billion CNY | -10.2% |
| 2023 Q1 | 2.63 Billion CNY | 28.79% |
| 2022 Q1 | 1.83 Billion CNY | 13.05% |
| 2022 Q4 | 2.04 Billion CNY | 14.57% |
| 2022 Q3 | 1.78 Billion CNY | -2.4% |
| 2022 FY | 7.5 Billion CNY | 14.37% |
| 2022 Q2 | 1.83 Billion CNY | 0.1% |
| 2021 Q3 | 1.38 Billion CNY | -22.09% |
| 2021 Q1 | 1.76 Billion CNY | 29.34% |
| 2021 Q2 | 1.78 Billion CNY | 0.84% |
| 2021 Q4 | 1.61 Billion CNY | 16.61% |
| 2021 FY | 6.56 Billion CNY | 9.23% |
| 2020 Q4 | 1.36 Billion CNY | 1.06% |
| 2020 Q1 | 1.7 Billion CNY | 41.36% |
| 2020 FY | 6 Billion CNY | 7.13% |
| 2020 Q3 | 1.35 Billion CNY | -14.37% |
| 2020 Q2 | 1.57 Billion CNY | -7.4% |
| 2019 Q2 | 1.48 Billion CNY | -8.38% |
| 2019 FY | 5.6 Billion CNY | 7.65% |
| 2019 Q1 | 1.61 Billion CNY | 29.61% |
| 2019 Q3 | 1.29 Billion CNY | -12.34% |
| 2019 Q4 | 1.2 Billion CNY | -7.11% |
| 2018 Q2 | 1.27 Billion CNY | -10.37% |
| 2018 Q3 | 1.27 Billion CNY | 0.13% |
| 2018 FY | 5.2 Billion CNY | 15.33% |
| 2018 Q1 | 1.41 Billion CNY | 33.33% |
| 2018 Q4 | 1.24 Billion CNY | -1.87% |
| 2017 Q3 | 1.04 Billion CNY | -5.28% |
| 2017 Q1 | 1.29 Billion CNY | 24.74% |
| 2017 Q2 | 1.1 Billion CNY | -14.47% |
| 2017 FY | 4.51 Billion CNY | 12.47% |
| 2017 Q4 | 1.06 Billion CNY | 1.29% |
| 2016 FY | 4.01 Billion CNY | 11.62% |
| 2016 Q3 | 977.96 Million CNY | -1.58% |
| 2016 Q2 | 993.66 Million CNY | -1.11% |
| 2016 Q1 | 1 Billion CNY | 21.99% |
| 2016 Q4 | 1.03 Billion CNY | 6.19% |
| 2015 FY | 3.59 Billion CNY | 0.2% |
| 2015 Q1 | 999.52 Million CNY | -1.15% |
| 2015 Q4 | 823.7 Million CNY | -0.15% |
| 2015 Q3 | 824.91 Million CNY | -13.06% |
| 2015 Q2 | 948.88 Million CNY | -5.07% |
| 2014 Q3 | 841.78 Million CNY | -2.85% |
| 2014 Q4 | 1.01 Billion CNY | 20.12% |
| 2014 FY | 3.58 Billion CNY | 13.25% |
| 2014 Q1 | 870.33 Million CNY | 10.39% |
| 2014 Q2 | 866.47 Million CNY | -0.44% |
| 2013 Q1 | 739.08 Million CNY | 6.81% |
| 2013 Q3 | 764.08 Million CNY | -12.98% |
| 2013 FY | 3.16 Billion CNY | 6.67% |
| 2013 Q4 | 788.42 Million CNY | 3.19% |
| 2013 Q2 | 878.05 Million CNY | 18.8% |
| 2012 Q3 | 741.65 Million CNY | -3.36% |
| 2012 Q2 | 767.46 Million CNY | -0.39% |
| 2012 FY | 2.97 Billion CNY | 1.16% |
| 2012 Q1 | 770.46 Million CNY | 14.69% |
| 2012 Q4 | 691.93 Million CNY | -6.7% |
| 2011 Q4 | 671.78 Million CNY | -9.58% |
| 2011 Q1 | 844.63 Million CNY | 48.61% |
| 2011 Q2 | 678.18 Million CNY | -19.71% |
| 2011 Q3 | 742.93 Million CNY | 9.55% |
| 2011 FY | 2.93 Billion CNY | 12.37% |
| 2010 Q3 | 677.25 Million CNY | 8.27% |
| 2010 FY | 2.61 Billion CNY | 12.59% |
| 2010 Q1 | 743.11 Million CNY | 44.18% |
| 2010 Q2 | 625.5 Million CNY | -15.83% |
| 2010 Q4 | 568.36 Million CNY | -16.08% |
| 2009 Q3 | 609.73 Million CNY | 3.2% |
| 2009 Q2 | 590.84 Million CNY | -2.49% |
| 2009 FY | 2.32 Billion CNY | 10.73% |
| 2009 Q1 | 605.94 Million CNY | 35.05% |
| 2009 Q4 | 515.39 Million CNY | -15.47% |
| 2008 FY | 2.09 Billion CNY | 11.13% |
| 2008 Q4 | 448.67 Million CNY | -11.61% |
| 2008 Q3 | 507.63 Million CNY | -11.49% |
| 2008 Q2 | 573.52 Million CNY | 1.13% |
| 2008 Q1 | 567.13 Million CNY | 23.65% |
| 2007 Q2 | 486.5 Million CNY | 0.86% |
| 2007 Q1 | 482.37 Million CNY | 16.95% |
| 2007 FY | 1.88 Billion CNY | 13.18% |
| 2007 Q4 | 458.66 Million CNY | -0.17% |
| 2007 Q3 | 459.43 Million CNY | -5.56% |
| 2006 Q4 | 412.46 Million CNY | 4.91% |
| 2006 Q3 | 393.15 Million CNY | -1.98% |
| 2006 Q2 | 401.09 Million CNY | -12.91% |
| 2006 FY | 1.66 Billion CNY | -1.72% |
| 2006 Q1 | 460.54 Million CNY | 12.92% |
| 2005 Q2 | 424.02 Million CNY | -5.28% |
| 2005 Q4 | 407.84 Million CNY | -2.19% |
| 2005 Q3 | 416.98 Million CNY | -1.66% |
| 2005 FY | 1.69 Billion CNY | 12.26% |
| 2005 Q1 | 447.65 Million CNY | 26.87% |
| 2004 Q3 | 356.32 Million CNY | -12.84% |
| 2004 Q1 | 393.32 Million CNY | 20.9% |
| 2004 FY | 1.51 Billion CNY | 13.76% |
| 2004 Q2 | 408.81 Million CNY | 3.94% |
| 2004 Q4 | 352.83 Million CNY | -0.98% |
| 2003 FY | 1.32 Billion CNY | 13.2% |
| 2003 Q3 | 325.77 Million CNY | 0.18% |
| 2003 Q2 | 325.2 Million CNY | -7.65% |
| 2003 Q1 | 352.14 Million CNY | 20.66% |
| 2003 Q4 | 325.34 Million CNY | -0.13% |
| 2002 Q2 | 293.74 Million CNY | -4.13% |
| 2002 Q1 | 306.4 Million CNY | 0.0% |
| 2002 Q3 | 281.56 Million CNY | -4.15% |
| 2002 Q4 | 291.84 Million CNY | 3.65% |
| 2002 FY | 1.17 Billion CNY | 6.76% |
| 2001 FY | 1.09 Billion CNY | 5.29% |
| 2000 FY | 1.04 Billion CNY | 9.83% |
| 1999 FY | 950.66 Million CNY | -2.38% |
| 1998 FY | 973.88 Million CNY | 6.36% |
| 1997 FY | 915.63 Million CNY | 8.72% |
| 1996 FY | 842.2 Million CNY | 18.3% |
| 1995 FY | 711.89 Million CNY | 33.4% |
| 1994 FY | 533.67 Million CNY | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Pak Fah Yeow International Limited | 259.15 Million HKD | -3025.832% |
| Grand Pharmaceutical Group Limited | 10.52 Billion HKD | 23.066% |
| Extrawell Pharmaceutical Holdings Limited | 59.09 Million HKD | -13607.477% |
| Wai Yuen Tong Medicine Holdings Limited | 783.88 Million HKD | -933.428% |
| Qianhai Health Holdings Limited | 961.29 Million HKD | -742.705% |
| Lee's Pharmaceutical Holdings Limited | 1.05 Billion HKD | -669.286% |
| Essex Bio-Technology Limited | 1.7 Billion HKD | -374.69% |
| Tongfang Kontafarma Holdings Limited | 809.1 Million HKD | -901.208% |
| PuraPharm Corporation Limited | 406.85 Million HKD | -1891.069% |
| SSY Group Limited | 6.46 Billion HKD | -25.342% |
| JBM (Healthcare) Limited | 648.41 Million HKD | -1149.33% |
| Jacobson Pharma Corporation Limited | 1.46 Billion HKD | -451.905% |
| China Resources Pharmaceutical Group Limited | 270.39 Billion HKD | 97.004% |